Midori Lucia Wasielewski

Mrs. Midori Lucia Wasielewski

Georgia Institute of Technology, Atlanta, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2018 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
Midori Lucia WasielewskiMidori Lucia Wasielewski
Midori Lucia Wasielewski
TKTaisuke Kojima
Taisuke Kojima
YSYang Song
Yang Song
STShuichi Takayama
Shuichi Takayama

Verified
Journal Article
Open access
PDF file
Midori Lucia WasielewskiMidori Lucia Wasielewski
Midori Lucia Wasielewski
KNKatherine Hao Nguyen
Katherine Hao Nguyen
SYSrilakshmi Yalavarthi
Srilakshmi Yalavarthi
PEPallavi Ekbote
Pallavi Ekbote
PWPriyan Weerappuli
Priyan Weerappuli
STShuichi Takayama
Shuichi Takayama
This study analyzed the nuclease- and serum-driven degradation of millimeter-scale, circular DNA–histone mesostructures (DHMs). DHMs are bioengineered chromatin meshes of defined DNA and histone compositions designed as minimal mimetics of physiological extracellular chromatin structures, such as neutrophil extracellular traps (NETs). Taking advantage of the defined circular shape of the DHMs, an automated time-lapse imaging and image analysis method was developed and used to track DHM degradation and shape changes over time. DHMs were degraded well by 10 U/mL concentrations of deoxyribonuclease I (DNase I) but not by the same level of micrococcal nuclease (MNase), whereas NETs were degraded well by both nucleases. These comparative observations suggest that DHMs have a less accessible chromatin structure compared to NETs. DHMs were degraded by normal human serum, although at a slower rate than NETs. Interestingly, time-lapse images of DHMs revealed qualitative differences in the serum-mediated degradation process compared to that mediated by DNase I. Importantly, despite their reduced susceptibility to degradation and compositional simplicity, the DHMs mimicked NETs in being degraded to a greater extent by normal donor serum compared to serum from a lupus patient with high disease activity. These methods and insights are envisioned to guide the future development and expanded use of DHMs, beyond the previously reported antibacterial and immunostimulatory analyses, to extracellular chromatin-related pathophysiological and diagnostic studies.

19 April 2025 in Cells
Verified
Journal Article
Open access
PDF file
KNKatherine Hao Nguyen
Katherine Hao Nguyen
Midori Lucia WasielewskiMidori Lucia Wasielewski
Midori Lucia Wasielewski
SYSrilakshmi Yalavarthi
Srilakshmi Yalavarthi
XQXianggui Qu
Xianggui Qu
JKJason Knight
Jason Knight
STShuichi Takayama
Shuichi Takayama
Neutrophil extracellular traps (NETs) are not only promising biomarkers of disease, but also potential therapeutic targets. Overproduction or the improper clearance of NETs has been linked to disease severity. In vitro NET degradation assays can reveal mechanisms and degradation efficiency differences in diseased serum samples. There is a need for more convenient assays to increase the speed of NET degradation studies. This paper describes a simplified, lower variability mimetic assay with DNA–histone structures, referred to as surface webs, that performs functionally similarly to traditional NET degradation assays with increased scalability, ease of use, shorter preparation time, and lowered costs. The surface webs are created and dehydrated in a 96-well microplate that is shelf-stable, transportable, and viable for 30 days of storage at room temperature. The surface webs, compared to NETs, have similar shapes and distribution but lower intraplate variability while degrading with healthy serum and DNase I within the same timeframe. The assay can identify patient serum with reduced degradation capabilities. This assay opens new opportunities for NET-targeted drug discovery and studies on the role of NETs as modulators of disease.